?BIOINFORMATICS GROUP The scale of research in the life sciences is increasing rapidly, due in part to the growing ubiquity of ?omics?. High-throughput and high-dimensional assay technologies, including variations of DNA sequencing, array/lab-on-a-chip assays, mass spectrometry, nuclear magnetic resonance spectroscopy, and other technologies, allow investigators to study entire genomes, transcriptomes, proteomes, metabolomes, microbiomes, and other large-scale systems. Researchers examine biological systems holistically, looking for patterns and emergent properties or simply cast a wide net by measuring many more variables simultaneously in an experiment. DAIT-funded investigators are increasingly using these approaches. Advances in information technology also drive the increasing scale of research by facilitating the creation, sharing, pooling, and analysis of large databases of research data. Bioinformatics meets these scalability opportunities and challenges by applying techniques from computing, statistics, mathematics, and engineering to the management, analysis, and dissemination of large and or complex biological data sets. The Bioinformatics Group (BG) will serve as a core component of the DAIT Statistical and Clinical Coordinating Center and will help maximize the value of data collected by DAIT-sponsored clinical and mechanistic investigators by fostering long-term capacity for data sharing and utilization by the general research community. Building on Rho's extensive experience as a Statistical and Clinical Coordinating Center for a number of NIH and DAIT research networks, the BG will play a role in every stage of the data lifecycle: During study planning the BG will provide expert guidance to investigators on experimental design, emerging technologies, and analytical approaches, particularly with regards to the application of omics and other high- dimensional data types. The team will collaborate with investigators and other bioinformatics organizations to develop data standards for clinical and mechanistic data and apply those to DAIT study data sets and information systems developed by the center. Implementing these standards will ensure that data are consistently structured and annotated and will make them more easily shared and pooled. The BG will provide tools, high performance computing infrastructure, and analytical support for high-throughput and high- dimensional data sets. Finally, it will serve as the primary conduit for data dissemination from supported DAIT programs through the development of study portals for live data access and transfer of final study data sets to public repositories, such as ImmPort and TrialShare.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Program Project or Center with Complex Structure Cooperative Agreement (UM2)
Project #
1UM2AI117870-01
Application #
8892720
Study Section
Special Emphasis Panel (ZAI1-PA-I (J2))
Project Start
2015-05-07
Project End
2022-04-30
Budget Start
2015-05-07
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
$343,561
Indirect Cost
$127,485
Name
Rho Federal Systems Division, Inc.
Department
Type
DUNS #
362726007
City
Chapel Hill
State
NC
Country
United States
Zip Code
27517
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138
Gill, Michelle A; Liu, Andrew H; Calatroni, Agustin et al. (2018) Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol 141:1735-1743.e9
Wildfire, Jeremy; Bailey, Ryan; Krouse, Rebecca Z et al. (2018) The Safety Explorer Suite: Interactive Safety Monitoring for Clinical Trials. Ther Innov Regul Sci 52:696-700
Simpson, Eric L; Villarreal, Miguel; Jepson, Brett et al. (2018) Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. J Invest Dermatol 138:2224-2233
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Gergen, Peter J; Mitchell, Herman E; Calatroni, Agustin et al. (2018) Sensitization and Exposure to Pets: The Effect on Asthma Morbidity in the US Population. J Allergy Clin Immunol Pract 6:101-107.e2
du Toit, George; Sayre, Peter H; Roberts, Graham et al. (2018) Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort. J Allergy Clin Immunol 141:1343-1353
Lawson, K; Bahnson, H T; Brittain, E et al. (2017) Letter of response to Greenhawt et al. 'LEAPing Through the Looking Glass: Secondary Analysis of the Effect of Skin Test Size and Age of Introduction on Peanut Tolerance after Early Peanut Introduction'. Allergy 72:1267-1271
Liu, Haiyun; Archer, Nathan K; Dillen, Carly A et al. (2017) Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses. Cell Host Microbe 22:653-666.e5
Calabrese, Sarah K; Krakower, Douglas S; Mayer, Kenneth H (2017) Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities. Am J Public Health 107:1883-1889

Showing the most recent 10 out of 33 publications